Their findings suggested that the presence of an MEFV variant may influence the SLE phenotype, with carriers displaying a higher prevalence of inflammatory manifestations but a reduced risk of developing renal disease, potentially due to the protective effects of CRP and SAP. Here, CRP is linked to systemic lupus erythematosus.